Keyphrases
Pulmonary Arterial Hypertension
83%
Hispanic Patients
65%
Hispanic
49%
Hispanic Male
44%
Hispanic Population
35%
Risk Stratification System
33%
Pharmacotherapy
33%
Myopericarditis
33%
Heart Failure with Preserved Ejection Fraction (HFpEF)
33%
Atrial Fibrillation
28%
Beta-blockers
26%
Central Nervous System
26%
Pulmonary Hypertension
23%
Young Female
22%
Risk Score
21%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
21%
Permanent Pacemaker
20%
Clinical Outcomes
19%
Metabolic Syndrome
19%
Patient Demographics
18%
Hypo
16%
Renal Amyloidosis
16%
Coronary Artery Calcium Score
16%
Reversal Agents
16%
Clinical Role
16%
Left Ventricular Mass
16%
Mass Change
16%
Nocardiosis
16%
Disseminated Nocardiosis
16%
Activated Clotting Time
16%
Common Risks
16%
Bivalirudin
16%
Paraneoplastic Limbic Encephalitis
16%
Coronary Heart Disease Mortality
16%
Cardiovascular Mortality
16%
Liver Abnormality
16%
Contemporary Review
16%
AIDS/HIV
16%
Pneumatic Dilatation
16%
HyPer
16%
Time Response
16%
Idarucizumab
16%
Heroin Users
16%
Dabigatran
16%
Lymphocytopenia
16%
Skin Popping
16%
Risk Prediction
16%
Time to Clinical Worsening
16%
Percutaneous Coronary Intervention
16%
Brain Abscess
16%
Medicine and Dentistry
Pulmonary Hypertension
100%
Risk Stratification
33%
Patient Population
28%
Brain Natriuretic Peptide
25%
Coronary Artery Disease
25%
Central Nervous System
23%
Disease
23%
Drug Therapy
22%
Permanent Pacemaker
20%
Cardiovascular Disease
20%
Amino Terminal Sequence
19%
Diarrhea
19%
Human Immunodeficiency Virus
19%
Metabolic Syndrome
18%
Atrial Fibrillation
18%
Pyridostigmine
16%
Cannabis
16%
Kidney Amyloidosis
16%
Cannabis Use
16%
Skin Popping
16%
Achalasia
16%
Nocardiosis
16%
Calcium Channel Blocking Agent
16%
Colitis
16%
DRESS Syndrome
16%
Beta Adrenergic Receptor Blocking Agent
16%
Liver Fibrosis
16%
Esophagus Perforation
16%
Stenting
16%
Lymphocytopenia
16%
Rumination Syndrome
16%
Lung Hemodynamics
16%
Amelanotic Melanoma
16%
Cardiovascular System
16%
Cocaine Abuse
16%
New-Onset Atrial Fibrillation
16%
Dilated Cardiomyopathy
16%
Ciprofloxacin
16%
Myasthenia gravis
16%
Heart Failure with Preserved Ejection Fraction
16%
Diamorphine
16%
Malignant Neoplasm
16%
Serum Amyloid A
16%
Paraneoplastic Cerebellar Degeneration
16%
Myocardial Disease
16%
Coronary Artery Calcium
16%
Disease Course
16%
Echocardiography
15%
Computer Assisted Tomography
13%
Isocitrate Lyase
13%
